RxDoctor Payments Data

Rocky Howell, NP

Psychiatric/Mental Health · Payson, UTNPI 1225580186

Payments from drug & device makers

$656in general payments, 2019–2025

Across 43 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$466
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$47
  • Otsuka America Pharmaceutical, Inc.$36
  • Sunovion Pharmaceuticals Inc.$24
  • Johnson & Johnson$21
  • Eisai Inc.$17
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$60993%
  • Education$477%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$656 in reported general payments places this provider in the 55th percentile of 393 psychiatric/mental health providers in Utah.

See all psychiatric/mental health providers in Utah

Medicare billing

Part B allowed, 2024
$24,838
Medicare patients
36
Services billed
316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate20$161,135
Abilify MaintenaAripiprazole45$123,967
VraylarCariprazine Hcl49$71,144
RexultiBrexpiprazole22$34,589
CaplytaLumateperone Tosylate16$29,421
TrintellixVortioxetine Hydrobromide17$10,394
BelsomraSuvorexant19$8,369
VyvanseLisdexamfetamine Dimesylate21$7,917
Lurasidone Hcl45$5,845
Paliperidone ErPaliperidone11$5,147
Aripiprazole73$4,321
Duloxetine Hcl131$3,219
Lamotrigine229$3,080
Lisdexamfetamine Dimesylate13$3,021
Quetiapine Fumarate195$2,954

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$36$158,55667 claims
AbbVieVraylar$466$71,14449 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$47$29,42116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 393 psychiatric/mental health providers in Utah.

Other psychiatric/mental health in Payson

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →